(INNS)
BARZOLVOLIMAB(INNC)
IMMUNOGLOBULIN G1-KAPPA, ANTI-[HOMO SAPIENS KIT (KIT PROTOONCOGENE RECEPTOR TYROSINE KINASE, C-KIT, C-KIT, SCFR, CD117) EXTRACELLULAR DOMAIN], MONOCLONAL ANTIBODY; GAMMA1 HEAVY CHAIN (1-445) [VH MUSMUS/HOMSAP (MUS MUSCULUS IGHV1-76*01 (87.8%) -(IGHD) -IGHJ2*01 (93.3%) L124>V (112)/HOMO SAPIENS IGHV1-2*06 (76.5%) -(IGHD) -IGHJ4*01 (93.3%) L123>T (111), CDR-IMGT [8.8.9] (26-33.51-58.97-105)) (1-116) -HOMO SAPIENS IGHG1*01, G1M17,1, G1V21 CH2 Y15.1, T16, E18, G1V20 CH2 A105 (CH1 K120 (213) (117-214), HINGE 1-15 (215-229), CH2 L1.3>A (233), L1.2>Q (234), M15.1>Y (251), S16>T (253), T18>E (255), K105>Q (321) (230-339), CH3 D12 (355), L14 (357) (340-444), CHS K>DEL (445)) (117-445)], (219-214')-DISULFIDE WITH KAPPA LIGHT CHAIN...; PROPOSED INN: LIST 125, RECOMMENDED INN: LIST 87(WHO)
BARZOLVOLIMABUM(INN)